Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
RSC Chemical Biology|June 8, 2026
Pharmacology of estrogen-related receptors (ERRs) agonistsMohamed O Radwan, Soumitra Guin, Thomas P Burris
Analytical Biochemistry|April 6, 2025
Development of radioligand binding assays for REV-ERBα and REV-ERBβThomas Koelblen, Elise P Burris, Thomas P Burris
Future Medicinal Chemistry|April 30, 2011
The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasisLaura A Solt, Douglas J Kojetin, Thomas P Burris
Current Opinion in Lipidology|May 14, 2010
Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeuticsLaura A Solt, Patrick R Griffin, Thomas P Burris
Mini Reviews in Medicinal Chemistry|August 17, 2005
The pharmacology of LXRLaura F Michael, Jeffrey M Schkeryantz, Thomas P Burris
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2025
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacityCyrielle Billon, Kevin Appourchaux, Isabelle Côté, et al.
Plos One|October 3, 2012
LXR-mediated inhibition of CD4+ T helper cellsLaura A Solt, Theodore M Kamenecka, Thomas P Burris
Chemistry & Biology|January 31, 2012
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunityThomas P Burris, Scott A Busby, Patrick R Griffin
Plos One|April 10, 2012
Regulation of expression of citrate synthase by the retinoic acid receptor-related orphan receptor α (RORα)Christine Crumbley, Yongjun Wang, Subhashis Banerjee, et al.
Biochemical Pharmacology|February 19, 2017
Rev-erb regulation of cholesterologenesisSadichha Sitaula, Jinsong Zhang, Fernanda Ruiz, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
RSC Chemical Biology|June 8, 2026
Pharmacology of estrogen-related receptors (ERRs) agonistsMohamed O Radwan, Soumitra Guin, Thomas P Burris
Analytical Biochemistry|April 6, 2025
Development of radioligand binding assays for REV-ERBα and REV-ERBβThomas Koelblen, Elise P Burris, Thomas P Burris
Future Medicinal Chemistry|April 30, 2011
The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasisLaura A Solt, Douglas J Kojetin, Thomas P Burris
Current Opinion in Lipidology|May 14, 2010
Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeuticsLaura A Solt, Patrick R Griffin, Thomas P Burris
Mini Reviews in Medicinal Chemistry|August 17, 2005
The pharmacology of LXRLaura F Michael, Jeffrey M Schkeryantz, Thomas P Burris
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2025
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacityCyrielle Billon, Kevin Appourchaux, Isabelle Côté, et al.
Plos One|October 3, 2012
LXR-mediated inhibition of CD4+ T helper cellsLaura A Solt, Theodore M Kamenecka, Thomas P Burris
Chemistry & Biology|January 31, 2012
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunityThomas P Burris, Scott A Busby, Patrick R Griffin
Plos One|April 10, 2012
Regulation of expression of citrate synthase by the retinoic acid receptor-related orphan receptor α (RORα)Christine Crumbley, Yongjun Wang, Subhashis Banerjee, et al.
Biochemical Pharmacology|February 19, 2017
Rev-erb regulation of cholesterologenesisSadichha Sitaula, Jinsong Zhang, Fernanda Ruiz, et al.
Pageof 17